Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

TSX:ASM
TSX:ASMMetals and Mining

A Look At Avino Silver & Gold Mines (TSX:ASM) Valuation After La Preciosa Progress And Strong 2025 Production

Avino Silver & Gold Mines (TSX:ASM) is back in focus after reporting its 2025 operating results and providing a detailed La Preciosa update, combining mine performance, project progress, and safety metrics. See our latest analysis for Avino Silver & Gold Mines. The latest production and La Preciosa updates arrive after a sharp re rating, with the share price at CA$10.76, a 90 day share price return of 57.54% and a very large 1 year total shareholder return. This suggests momentum has been...
NYSE:F
NYSE:FAuto

Ford’s New FDIC Bank And EV Pivot Could Be A Game Changer For Ford Motor (F)

In recent days, Ford received federal approval to launch Ford Credit Bank as an FDIC‑insured institution, while also confirming a major U.S. product pivot away from large electric trucks like the F‑150 Lightning toward hybrids and smaller, lower-cost EVs. Together, access to insured deposits for auto lending and the refocus on more affordable electrified models mark a significant reshaping of Ford’s business model and profit mix. With this backdrop, we’ll explore how Ford’s move into...
NYSE:FDX
NYSE:FDXLogistics

Is It Time To Reassess FedEx (FDX) After Recent Valuation Signals?

If you are wondering whether FedEx is offering fair value at its current price, this article walks through what the numbers are saying about the stock today. FedEx shares last closed at US$309.81, with returns of a 1.1% decline over the past 7 days, 4.9% over 30 days, 5.7% year to date, 17.4% over 1 year, 73.8% over 3 years, and 40.5% over 5 years. Recent headlines around FedEx have focused on its role in global shipping and logistics and how parcel volumes and network efficiency are...
NYSE:AN
NYSE:ANSpecialty Retail

Is It Too Late To Consider AutoNation (AN) After A 203% Five Year Rally?

If you are wondering whether AutoNation's share price still offers value after a strong run, or if most of the opportunity is already priced in, this article is designed to help you frame that question clearly. AutoNation's stock closed at US$219.08, with returns of 2.2% over the last 7 days, 4.3% over 30 days, 6.1% year to date, 18.3% over 1 year, 86.5% over 3 years and 203.1% over 5 years. This naturally raises questions about what is already reflected in the current valuation. Recent news...
NasdaqGS:MAR
NasdaqGS:MARHospitality

Assessing Marriott International (MAR) Valuation After Strong Multi‑Year Share Price Momentum

What recent performance says about Marriott International (MAR) With no single headline event driving attention today, interest in Marriott International (MAR) is instead centering on its recent share performance and fundamentals, including its month and past 3 months returns and current valuation metrics. See our latest analysis for Marriott International. At a share price of $321.67, Marriott International’s recent 90 day share price return of 18.56% and 1 year total shareholder return of...
NYSE:UE
NYSE:UERetail REITs

How Investors May Respond To Urban Edge Properties (UE) Expanding Undrawn US$950 Million Credit Capacity

On January 22, 2026, Urban Edge Properties announced it had entered into US$950 million of unsecured credit facilities, including a US$700 million revolving credit line maturing in June 2030 and US$250 million of delayed-draw term loans with staggered maturities out to January 2033. By expanding borrowing capacity, extending debt maturities, and keeping the facilities undrawn, the company has increased its financial flexibility to fund growth, development and general corporate needs on its...
NYSE:ADX
NYSE:ADXCapital Markets

Does ADX’s Stock or Cash Distribution Choice Reveal a Deeper Shift in Capital Return Strategy?

Adams Diversified Equity Fund, Inc. announced on January 15, 2026, a $0.47 per-share distribution payable on February 27, 2026, to shareholders of record as of January 26, 2026, with payment available in additional common shares by default or in cash upon timely election. This optional stock-or-cash structure is particularly important for investors because it lets them tailor the form of their return without changing their holdings outright. We’ll now examine how this flexible stock-or-cash...
TSX:DXT
TSX:DXTCommercial Services

3 TSX Companies Estimated To Be Priced Below Their Intrinsic Values

Amid a barrage of geopolitical tensions and U.S. policy developments, the Canadian market has shown remarkable resilience, with the TSX hitting record highs as fundamentals like low energy prices and solid growth continue to anchor stability. In this environment, identifying stocks priced below their intrinsic values can offer investors potential opportunities; focusing on strong fundamentals becomes key in navigating these complex market dynamics.
NasdaqGS:GOOGL
NasdaqGS:GOOGLInteractive Media and Services

This Week In Cloud AI - Unlocking Unstructured Data with Rocket ContentEdge Innovation

Rocket Software has unveiled Rocket® ContentEdge™, a new solution designed to unlock the value of unstructured data while ensuring safety and compliance in data modernization efforts. With features such as safety-first generative AI, automation, and seamless integration capabilities, ContentEdge enables organizations to access critical unstructured information securely across diverse environments without disrupting existing operations. This launch addresses the challenge many organizations...
TSXV:ONE
TSXV:ONESoftware

TSX Highlights: kneat.com And 2 Other Noteworthy Penny Stocks

The Canadian market continues to exhibit remarkable stability, with fundamentals such as low energy prices and moderating inflation anchoring its resilience despite a flurry of geopolitical and policy headlines. Penny stocks, though an outdated term, still represent an intriguing segment of the market by highlighting smaller or less-established companies that can offer significant value. By focusing on those with strong financials and clear growth potential, investors may uncover...
NYSE:VZ
NYSE:VZTelecom

Is Verizon (VZ) Pricing Make Sense After Mixed Multi‑Year Share Performance?

If you are wondering whether Verizon Communications is offering fair value at around US$39.48, you are not alone. This article is built to help you frame that question clearly. Over the last week the stock is up 0.3%, while the 30 day return is a 1.1% decline. Year to date it is down 2.6% and the 1 year return sits at 7.7%, compared with a 20.2% return over 3 years and a 3.2% decline over 5 years. Recent attention on Verizon has been shaped by ongoing debates around telecom capital spending,...
NYSE:HL
NYSE:HLMetals and Mining

Hecla Mining (HL) Is Up 24.1% After Silver Rally and Brighter Analyst Outlook - What's Changed

In recent trading, Hecla Mining drew attention after news highlighted its strong standing within the Basic Materials sector and a more favorable analyst outlook, coinciding with a powerful rally in silver prices tied to geopolitical tensions, supply constraints, and growing industrial uses. This episode underlines how Hecla’s exposure to silver links its investment story not only to precious‑metal sentiment but also to longer‑term trends in AI and solar technology demand. With that...
NasdaqGM:SFST
NasdaqGM:SFSTBanks

Sharp Margin Improvement At Southern First Bancshares (SFST) Challenges Cautious Earnings Narratives

Southern First Bancshares (SFST) closed out FY 2025 with fourth quarter total revenue of US$31.2 million and basic EPS of US$1.23, capping a trailing twelve month EPS figure of US$3.77 on total revenue of US$115.1 million. The company has seen quarterly revenue move from US$25.4 million in Q4 2024 to US$31.2 million in Q4 2025, while basic EPS over that same period went from US$0.70 to US$1.23. This sets up a story where higher net profit margins and stronger earnings levels are front and...
NYSE:ELV
NYSE:ELVHealthcare

Elevance Health Lobbying And Congressional Trading Put Policy Risks In Focus

Elevance Health disclosed about $1.53 million in lobbying in recent filings, focused on ACA Exchanges, Mental Health Parity, Medicare and Medicaid programs, and Pharmacy Benefit Manager reforms. Recent disclosures also show multiple instances of Congressional trading in Elevance Health (NYSE:ELV) stock during the same general period. These developments highlight how the company is engaging with policymakers while lawmakers themselves are active in the stock. For investors tracking Elevance...
NasdaqGS:CORZ
NasdaqGS:CORZSoftware

How Investors May Respond To Core Scientific (CORZ) Pivot Toward AI And HPC Infrastructure Services

Earlier in January, BTIG upgraded Core Scientific to a Buy rating, citing the company’s ongoing pivot from Bitcoin mining to high-density infrastructure and colocation services for artificial intelligence and high-performance computing clients. This marks a meaningful shift in Core Scientific’s business mix toward providing power, cooling, and specialized hosting for third-party AI and HPC workloads, rather than primarily mining Bitcoin on its own balance sheet. Next, we’ll examine how...
XTRA:DTG
XTRA:DTGMachinery

How Investors May Respond To Daimler Truck Holding (XTRA:DTG) Foxconn-Backed Electric Bus Venture In Japan

Daimler Truck’s Japan unit recently agreed with Foxconn to form a new company to manufacture electric buses, combining Fuso’s bus engineering with Foxconn’s zero-emission vehicle technology and manufacturing network. This cross-industry collaboration could reinforce Daimler Truck’s position in cleaner commercial transport by pairing established bus design capabilities with high-volume electric platform know-how. We’ll now examine how this new Foxconn-backed electric bus venture shapes...
NYSE:MRK
NYSE:MRKPharmaceuticals

Merck Weighs mRNA Breakthrough And Revolution Deal Against Oncology Valuation

Merck (NYSE:MRK) and Moderna released five-year clinical data on a personalized mRNA cancer vaccine regimen used with Keytruda in high-risk melanoma. The follow-up results point to a meaningful improvement in outcomes for skin cancer patients treated in the study. Separately, Merck is reported to be in advanced discussions to acquire Revolution Medicines, a move connected to its oncology pipeline ahead of key patent expirations. For you as an investor, this pairs Merck’s core strength in...